MetaLabs Co Ltd Cash Flow Conversion Efficiency
MetaLabs Co Ltd cash flow conversion efficiency. Based on the latest financial reports, MetaLabs Co Ltd (090370) has a cash flow conversion efficiency ratio of 0.007x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.03 Billion ≈ $700.90K USD) by net assets (₩141.52 Billion ≈ $95.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MetaLabs Co Ltd (2013–2025)
Cash flow conversion efficiency of MetaLabs Co Ltd from 2013 to 2025. This chart illustrates how MetaLabs Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MetaLabs Co Ltd stock quote for real-time trading data and today's change.
MetaLabs Co Ltd Cash Flow Conversion Ratio Explained
MetaLabs Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MetaLabs Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MetaLabs Co Ltd ranked by their cash flow conversion efficiency. Also see 090370 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Y&G Corp Bhd
KLSE:7003
|
0.094x |
|
Carlin Gold Corporation
V:CGD
|
-0.013x |
|
Is Girisim Sermayesi Yatirim Ortakligi AS
IS:ISGSY
|
-0.007x |
|
MYMBN Berhad
KLSE:0280
|
-0.062x |
|
Neuphoria Therapeutics Inc
NASDAQ:NEUP
|
0.048x |
|
Raytech Holding Limited Ordinary Shares
NASDAQ:RAY
|
-0.125x |
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
-0.077x |
|
Enzo Biochem Inc
NYSE:ENZ
|
-0.074x |
Annual Cash Flow Conversion Efficiency for MetaLabs Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of MetaLabs Co Ltd from 2013 to 2025. Review MetaLabs Co Ltd (090370) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩141.82 Billion ≈ $96.11 Million |
₩-2.50 Billion ≈ $-1.69 Million |
-0.018x | +63.45% |
| 2024-12-31 | ₩79.45 Billion ≈ $53.84 Million |
₩-3.83 Billion ≈ $-2.59 Million |
-0.048x | -7032.94% |
| 2023-12-31 | ₩73.40 Billion ≈ $49.74 Million |
₩-49.57 Million ≈ $-33.59K |
-0.001x | -111.90% |
| 2022-12-31 | ₩78.89 Billion ≈ $53.46 Million |
₩447.64 Million ≈ $303.36K |
0.006x | -85.95% |
| 2021-12-31 | ₩56.43 Billion ≈ $38.24 Million |
₩2.28 Billion ≈ $1.54 Million |
0.040x | +58.37% |
| 2020-12-31 | ₩53.46 Billion ≈ $36.23 Million |
₩1.36 Billion ≈ $924.10K |
0.026x | +137.17% |
| 2019-12-31 | ₩58.61 Billion ≈ $39.72 Million |
₩-4.02 Billion ≈ $-2.73 Million |
-0.069x | +27.13% |
| 2018-12-31 | ₩73.25 Billion ≈ $49.64 Million |
₩-6.90 Billion ≈ $-4.67 Million |
-0.094x | +66.26% |
| 2017-12-31 | ₩30.34 Billion ≈ $20.56 Million |
₩-8.47 Billion ≈ $-5.74 Million |
-0.279x | +34.85% |
| 2016-12-31 | ₩23.38 Billion ≈ $15.84 Million |
₩-10.01 Billion ≈ $-6.79 Million |
-0.428x | -6.59% |
| 2015-12-31 | ₩19.62 Billion ≈ $13.29 Million |
₩-7.88 Billion ≈ $-5.34 Million |
-0.402x | -103.62% |
| 2014-12-31 | ₩54.91 Billion ≈ $37.21 Million |
₩-10.84 Billion ≈ $-7.34 Million |
-0.197x | -506.43% |
| 2013-12-31 | ₩52.86 Billion ≈ $35.82 Million |
₩2.57 Billion ≈ $1.74 Million |
0.049x | -- |
About MetaLabs Co Ltd
Metalabs Co., Ltd. primarily provides clothing, miscellaneous goods, and accessories in South Korea. The company sell goods, such as cosmetics; operates hospital management support, block chain and virtual currency development services, etc.; and social dating services. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was f… Read more